Back to Insider Trading View Full Company Profile

URGN

CRITICAL

UroGen Pharma Ltd.

CIK: 0001668243

Strong Sell (70% confidence)

Last activity: Feb 3, 2026

Financial Metrics

As of Dec 31, 2025 (10-K)

Revenue $1.13M

Net Income -$153.49M

Total Debt $122.21M

Insider Roster (2 total, 2 active)

Insider	Buys	Sells	Net Value	Holdings
Schoenberg Mark Chief Medical Officer	0	4	-$395K	144,985 shares $2.85M
Smith Jason Drew General Counsel	0	3	-$147K	55,588 shares $1.09M

Recent Transactions

SELL Schoenberg Mark (Chief Medical Officer)

3,686 shares @ $19.69

$73K

Feb 3, 2026

Conviction: | View SEC Filing →

SELL Smith Jason Drew (General Counsel)

3,217 shares @ $19.69

$63K

Feb 3, 2026

Conviction: | View SEC Filing →

SELL Smith Jason Drew (General Counsel)

2,654 shares @ $19.69

$52K

Feb 3, 2026

Conviction: | View SEC Filing →

SELL Schoenberg Mark (Chief Medical Officer)

1,844 shares @ $19.69

$36K

Feb 3, 2026

Conviction: | View SEC Filing →

SELL Schoenberg Mark (Chief Medical Officer)

1,843 shares @ $19.69

$36K

Feb 3, 2026

Conviction: | View SEC Filing →

SELL Smith Jason Drew (General Counsel)

1,608 shares @ $19.69

$32K

Feb 3, 2026

Conviction: | View SEC Filing →

SELL Schoenberg Mark (Chief Medical Officer)

10,000 shares @ $25.00

$250K

Nov 19, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.